Literature DB >> 11384893

Syndromic validity of apathy in Alzheimer's disease.

S E Starkstein1, G Petracca, E Chemerinski, J Kremer.   

Abstract

OBJECTIVE: The study examined the usefulness and clinical correlates of specific diagnostic criteria for apathy in Alzheimer's disease. Whereas apathy is a frequent behavioral change in patients with Alzheimer's disease, the lack of standardized diagnostic criteria may explain the wide discrepancies in estimates of the frequency and demographic and clinical correlates of apathy.
METHOD: A consecutive series of 319 patients who met the criteria for probable Alzheimer's disease established by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association, 117 patients who met the DSM-IV criteria for depression without dementia, and 36 healthy individuals were assessed with a structured psychiatric interview. On the basis of modified Marin's criteria for apathy, they were classified into groups with or without apathy.
RESULTS: Apathy was diagnosed in 37% of the 319 Alzheimer's disease patients, compared to none of the healthy comparison subjects. In 24% of the Alzheimer's disease sample, apathy coexisted with either dysthymic disorder or major depressive disorder, whereas 13% had apathy without depression. Apathy was diagnosed in 32% of the depressed nondemented patients, mostly in those with major depressive disorder. Apathy in Alzheimer's disease was significantly associated with severe impairments in activities of daily living and cognitive functions, older age, and poor awareness of behavioral and cognitive changes.
CONCLUSIONS: This study provides partial validation of specific clinical criteria for apathy in Alzheimer's disease.

Entities:  

Mesh:

Year:  2001        PMID: 11384893     DOI: 10.1176/appi.ajp.158.6.872

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  71 in total

1.  Apathy and cognitive and functional decline in community-dwelling older adults: results from the Baltimore ECA longitudinal study.

Authors:  Diana E Clarke; Jean Y Ko; Constantine Lyketsos; George W Rebok; William W Eaton
Journal:  Int Psychogeriatr       Date:  2010-05-18       Impact factor: 3.878

Review 2.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

Review 3.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

4.  Stereotypic behaviors in degenerative dementias.

Authors:  S Prioni; V Fetoni; F Barocco; V Redaelli; C Falcone; P Soliveri; F Tagliavini; A Scaglioni; P Caffarra; L Concari; S Gardini; F Girotti
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

5.  Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.

Authors:  Eric Salmon; Daniela Perani; Karl Herholz; Patricia Marique; Elke Kalbe; Vjera Holthoff; Xavier Delbeuck; Bettina Beuthien-Baumann; Oriana Pelati; Solange Lespagnard; Fabienne Collette; Gaëtan Garraux
Journal:  Hum Brain Mapp       Date:  2006-07       Impact factor: 5.038

Review 6.  Treatment approaches to symptoms associated with frontotemporal degeneration.

Authors:  Tiffany W Chow
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 7.  Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings.

Authors:  Eric Ecklund-Johnson; Ivan Torres
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

8.  The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression.

Authors:  Adriano Zanello; Laurent Berthoud; Joseph Ventura; Marco C G Merlo
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

Review 9.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

10.  Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning.

Authors:  Jim Grigsby; Angela G Brega; Rachael E Bennett; James A Bourgeois; Andreea L Seritan; Glenn K Goodrich; Randi J Hagerman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.